this was accomplished by determining whether administration of receptor antagonists to vasopressin , [ 1- ( beta-mercapto-beta , beta-cyclopentamethylene propionic acid ) , 2- ( o-methyl ) tyrosine ] arg8-vasopressin , and ang ii ( saralasin ) , reduced the acth and glucocorticoid responses to infusion of four doses of the vasodilator nitroprusside .
C0003009
ang ii
C0036193
saralasin